University College London cancer treatment spinout Autolus licences additional technology from the university as it raises $57m in its series B round.

Ping An has contributed to a series A round for Prenetics, which develops DNA testing technology to help deliver more accurate diagnoses.

Microsure has been spun out by Eindhoven and Maastricht following an STW Take-Off grant gained in January 2016.

Ping An has contributed to a series A round for Prenetics, which develops DNA testing technology to help deliver more accurate diagnoses.

Takeda has co-launched Outpost Medicine, which will focus on therapies for urologic and gynaecologic conditions following a $41m funding round that included Novo.

The Novo and Roche-backed company, which has raised $108m in venture funding, is set to price 4.7 million shares at between $15 and $17.

Arterys, the developer of a medical imaging platform for blood flow, has completed a $12m round that included GE Ventures.

Prostate cancer diagnostics company GenomeDx Biosciences has raised $25.4m in its third round of equity funding, which appears to have included existing backer Merck & Co.

GV led the genome sequencing company's series B round, which followed a $5.5m series A in late 2014.

Osage University Partners backs a $15.8m investment for antibody discovery company Capella Bioscience.